Serán Bioscience
- Company typePrivate
- Founded2016
- HeadquartersBend, United States
- Headcount251–500
- GTM typeB2B
- OfferingServices
Serán Bioscience firmographics
Firmographics- Name
- Serán Bioscience
- Legal name
- Serán BioScience, LLC
- Website
- https://seranbio.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Ownership category
- akta.pro rank
Serán Bioscience industry classification
Industry- Product category
- Pharmaceutical Contract Development and Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Pharmaceutical Preparations (2834), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB)
- akta.pro secondary industries
- Drug Substance–Drug Product Integrated CDMO (HLAGABAG), Biologics (mAbs/Recombinant Proteins) CDMO (HLAGABAC)
Keywords
Where Serán Bioscience is headquartered
LocationHeadquarters
- HQ city
- Bend
- HQ country
- United States
- HQ region
- North America
Offices4 records
Markets served
Serán Bioscience business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales
Revenue model
- Contract Development and Manufacturing Services: Serán operates as a CDMO providing fee-for-service drug development and manufacturing to pharmaceutical and biotechnology companies. Services span from preclinical formulation through commercial-scale manufacturing of oral solid dose products. Revenue is generated through project-based contracts, time-and-materials arrangements, and potentially milestone-based payments for development programs.
- Commercial Manufacturing: Upon completion of the commercial manufacturing facility (Q2 2027), Serán will provide large-scale commercial production of oral solid dose pharmaceuticals. Revenue will be generated through long-term manufacturing contracts with pharmaceutical companies.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels5 records
Serán Bioscience product offering
Product offeringCore offering
Serán Bioscience is a science-driven CDMO providing integrated drug product development, formulation, and manufacturing services for oral solid dosage forms. Services span preformulation and API characterization, formulation development, dosage form design, spray drying and particle engineering for bioavailability enhancement, cGMP clinical manufacturing across 14 ISO 8 classified suites, analytical and quality control, and full-scale commercial manufacturing of small molecules and biologics. The company serves pharmaceutical and biotechnology clients from preclinical through commercial-scale production.
Product overview
Serán Bioscience is a science-driven Contract Development and Manufacturing Organization (CDMO) that provides integrated drug product development, formulation, and manufacturing solutions. The company operates eight core service offerings: Commercial Manufacturing (full-scale oral solid dose production with validation and tech transfer), Preformulation Services (API characterization), Formulation Development (QbD/DoE-driven oral solid dosage forms), Dosage Form Development (capsules, tablets, powder-in-bottle), Spray Drying and Particle Engineering (bioavailability enhancement via amorphous solid dispersions), cGMP Manufacturing (clinical production in ISO 8 suites), Analytical + Quality Control (method development and release testing), and Spray Drying of Biologics (biotherapeutic formulations). These services span from early discovery through commercial-scale production, enabling complex oral, pulmonary, and nasal drug delivery across small molecules and biologics.
Differentiator
Problem solved
Functional benefit
Products and services
- Commercial Manufacturing Full-scale commercial manufacturing of oral solid dosage forms with lifecycle-based process validation, technology transfer, scale-up services, and capabilities including spray drying, granulation, tableting, encapsulation, and coating. Designed for pharmaceutical and biotechnology companies advancing drug products through commercial launch and supply.
- Preformulation Services API characterization services including solid-state properties assessment, solubility screening, particle size analysis, dissolution studies, multifactorial stability screening, and preclinical formulation development. Used by pharmaceutical and biotech clients to understand molecule behavior early in development.
- Formulation Development Oral solid dosage form development engineered to meet solubility and release challenges using QbD and DoE principles, supporting preclinical through Phase III studies with material-sparing approaches. Targeted at pharmaceutical and biotechnology companies developing complex molecules.
- Dosage Form Development Development of solid dosages including capsules, tablets, and powder-in-bottle formulations engineered for solubility challenges and extended-release mechanisms with phase-appropriate strategies. Serves pharmaceutical and biotech clients across preclinical to clinical development stages.
- Spray Drying and Particle Engineering Bioavailability enhancement through spray drying for amorphous solid dispersions, with capabilities ranging from nanometers to hundreds of microns in particle size, supporting preclinical through commercial scale. Addresses poor solubility challenges for pharmaceutical and biotechnology clients.
- cGMP Manufacturing Clinical manufacturing capabilities for oral solid dosage forms including spray drying, hot melt extrusion, blending, milling, granulation, encapsulation, tablet compression, coating, and clinical packaging in ISO 8 classified suites. Serves pharmaceutical and biotech clients requiring Phase I-III clinical supply.
- Analytical + Quality Control State-of-the-art analytical laboratories supporting formulation development and cGMP quality control including method transfer, development, qualification, ICH stability testing, and environmental monitoring. Supports pharmaceutical and biotech clients with method development, validation, and release testing needs.
- Spray Drying of Biologics Spray drying expertise for biotherapeutic formulations including peptides, proteins, phages, and nucleic acids, enabling high-concentration protein suspensions, pulmonary delivery, and improved stability. Designed for pharmaceutical and biotechnology companies developing biologic drug products.
Quantifiable outcome
- Scale-up from preclinical to commercial with material-sparing approaches using only milligram quantities of API for early development
- +2 more outcomes
Companies that use Serán Bioscience
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles2 records
Serán Bioscience technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Serán Bioscience partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- Mortenson ConstructioncoreConstruction partner for the new commercial manufacturing campus in Bend, Oregon. Celebrated groundbreaking with Serán's Board of Directors and leadership.
- CRB GroupcoreDesign and construction partner for the new commercial manufacturing facility campus in Bend, Oregon.
- Blaise Cacciola (BCA)minorPartner involved in the construction and design of the commercial manufacturing campus.
Scale indicators8 records
Recent moves10 records
Expansion highlights5 records
Serán Bioscience competitors and assessment
Company assessmentBroad incumbents
- Lonza: Global CDMO leader with extensive oral solid dose and spray drying capabilities, including the former Bend Research operations that share lineage with Serán's Bend, Oregon expertise. Lonza competes across the full CDMO value chain Serán targets.
- Eurofins CDMO: Global CDMO services through Eurofins CDMO (formerly Alphapanel / Amatsigroup) offering formulation development, clinical manufacturing, and analytical services comparable to Serán's offerings.
- Catalent: Large diversified CDMO with significant oral solid dose and bioavailability enhancement capabilities including OptiMelt hot melt extrusion and similar formulation services. Competes for the same pharma and biotech clients Serán targets.
- Thermo Fisher Scientific (CDMO services): Through its Patheon CDMO business, Thermo Fisher is one of the largest global CDMOs with comprehensive oral solid dose development, clinical, and commercial manufacturing capabilities that overlap Serán's offering.
Direct peers
- Quotient Sciences: UK-based CDMO specializing in formulation development, clinical manufacturing, and integrated drug substance-to-drug product services for small molecules. Closely comparable service offering and customer base to Serán.
- Alcami: US-based CDMO offering formulation development, analytical services, and small-batch clinical manufacturing for oral solid dose and sterile products. A comparable mid-sized competitor in clinical-stage CDMO services.
- Hovione: Specialty CDMO with deep expertise in spray drying, particle engineering, and bioavailability enhancement for small molecules. Hovione competes directly with Serán's core spray-dried dispersion and amorphous solid dispersion offerings.
Others
- PharmaLex (now part of Cencora): Regulatory and development services provider serving similar pharma/biotech customers. Adjacent rather than directly competitive, but relevant context for the CDMO services ecosystem Serán operates in.
Emerging players
- Ascendia Pharmaceuticals: Smaller specialty CDMO focused on poorly soluble drugs and complex formulations including nanoemulsions, hot melt extrusion, and spray drying. Comparable technology stack but smaller scale than Serán.
- Aprecia Pharmaceuticals: CDMO with proprietary 3D-printed drug delivery technology and formulation development services for complex oral dosage forms. Adjacent competitor in novel oral drug delivery CDMO services.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Serán Bioscience social profiles
Digital presenceSerán Bioscience compliance and trust
Trust signalCompliance1 record
Serán Bioscience financial estimates
Financial estimateRevenue estimate
Valuation estimate
Serán Bioscience leadership team
Management profileNumber of profiles
Profiles15 records
Serán Bioscience funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Serán Bioscience M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Serán Bioscience
What does Serán Bioscience do?
Serán Bioscience is a science-driven CDMO providing integrated drug product development, formulation, and manufacturing services for oral solid dosage forms. Services span preformulation and API characterization, formulation development, dosage form design, spray drying and particle engineering for bioavailability enhancement, cGMP clinical manufacturing across 14 ISO 8 classified suites, analytical and quality control, and full-scale commercial manufacturing of small molecules and biologics. The company serves pharmaceutical and biotechnology clients from preclinical through commercial-scale production.
Is Serán Bioscience a public or private company?
Serán Bioscience is a private company. It is classified as venture growth investor backed and is currently operating.
When was Serán Bioscience founded?
Serán Bioscience was founded in 2016. It employs 251 to 500 people.
Where is Serán Bioscience based?
Serán Bioscience is headquartered in Bend, United States, in the North America region.
How does Serán Bioscience make money?
Two revenue lines are on record. Contract Development and Manufacturing Services are the primary driver. The others are commercial Manufacturing.
Who are Serán Bioscience's main competitors?
Broad incumbents on record are Lonza, Eurofins CDMO, Catalent and Thermo Fisher Scientific (CDMO services). Direct peers are Quotient Sciences, Alcami and Hovione. PharmaLex (now part of Cencora) is listed as an others. Emerging players are Ascendia Pharmaceuticals and Aprecia Pharmaceuticals.
Does Serán Bioscience have an API?
No public API is recorded for Serán Bioscience.
What industry is Serán Bioscience in?
Serán Bioscience's product category is Pharmaceutical Contract Development and Manufacturing. Its primary akta.pro industry code is HLAGABAB, Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO, with a secondary code of HLAGABAG, Drug Substance–Drug Product Integrated CDMO. Its NAICS code is 325412 and its SIC code is 2834.